Hepatic miRNA profiles and thyroid hormone homeostasis in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS)

Environmental Toxicology and Pharmacology

Volumn 41, Issue , 2016, Pages 201-210

  Dong, Hongyan ^a   Curran, Ivan ^b   Williams, Andrew ^a   Bondy, Genevieve ^b   Yauk, Carole L ^a   Wade, Michael G ^a  

^a Environmental Health Center   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

EMT; Liver; Microarray; miRNA; PFOS

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; MICRORNA; MICRORNA 122 5P; MICRORNA 200; MICRORNA 21 5P; MICRORNA 23B 3P; MICRORNA 24 3P; MICRORNA 27B 3P; ORGANOFLUORINE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POTASSIUM PERFLUOROOCTANESULFONATE; PREGNANE X RECEPTOR; SURFACTANT; THYROID HORMONE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON; PERFLUOROOCTANESULFONIC ACID; POTASSIUM INTAKE; TRANSCRIPTOME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MOTILITY; CLINICAL CHEMISTRY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXPOSURE; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; LIVER PARENCHYMA; LIVER TOXICITY; MALE; METABOLIC CLEARANCE; METASTASIS; MICROARRAY ANALYSIS; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THYROID HORMONE METABOLISM; TUMOR CELL; ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HOMEOSTASIS; LIVER; POTASSIUM INTAKE; SPRAGUE DAWLEY RAT;

ALKANESULFONIC ACIDS; ANIMALS; FLUOROCARBONS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HOMEOSTASIS; LIVER; MALE; MICRORNAS; POTASSIUM, DIETARY; RATS; RATS, SPRAGUE-DAWLEY; THYROID HORMONES; TRANSCRIPTOME;

EID: 84954322182     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.12.009     Document Type: Article

References (74)

1. Abbott B.D., Wolf C.J., Das K.P., Zehr R.D., Schmid J.E., Lindstrom A.B., Strynar M.J., Lau C. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod. Toxicol. 2009, 27:258-265.
2. Ahn H., Han T. Regulation of TGF-beta signaling by PKC depends on Tsc-22 inducibility. Mol. Cell. Biochem. 2012, 360:47-50.
3. Andersen M.E., Butenhoff J.L., Chang S.C., Farrar D.G., Kennedy G.L., Lau C., Olsen G.W., Seed J., Wallace K.B. Perfluoroalkyl acids and related chemistries - toxicokinetics and modes of action. Toxicol. Sci. 2008, 102:3-14.
4. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., Goldman L.R. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 2007, 115:1670-1676.
5. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125:279-284.
6. Bjork J.A., Butenhoff J.L., Wallace K.B. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes. Toxicology 2011, 288:8-17.
7. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
8. Butenhoff J.L., Chang S.C., Olsen G.W., Thomford P.J. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 2012, 293:1-15.
9. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602.
10. Chang S.C., Ehresman D.J., Bjork J.A., Wallace K.B., Parker G.A., Stump D.G., Butenhoff J.L. Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: toxicokinetics, thyroid hormone status, and related gene expression. Reprod. Toxicol. 2009, 27:387-399.
11. Chang S.C., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J.A., Froehlich J.W., Lau C., Singh R.J., Wallace K.B., Butenhoff J.L. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 2008, 243:330-339.
12. Chen T., Williams T.D., Mally A., Hamberger C., Mirbahai L., Hickling K., Chipman J.K. Gene expression and epigenetic changes by furan in rat liver. Toxicology 2012, 292:63-70.
13. Chiyomaru T., Seki N., Inoguchi S., Ishihara T., Mataki H., Matsushita R., Goto Y., Nishikawa R., Tatarano S., Itesako T., Nakagawa M., Enokida H. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. Int. J. Oncol. 2015, 46:487-496.
14. Cui X., Hwang J.T., Qiu J., Blades N.J., Churchill G.A. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 2005, 6:59-75.
15. Curran I., Hierlihy S.L., Liston V., Pantazopoulos P., Nunnikhoven A., Tittlemier S., Barker M., Trick K., Bondy G. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). J. Toxicol. Environ. Health A 2008, 71:1526-1541.
16. Elcombe C.R., Elcombe B.M., Foster J.R., Chang S.C., Ehresman D.J., Butenhoff J.L. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARalpha and CAR/PXR. Toxicology 2012, 293:16-29.
17. Elcombe C.R., Elcombe B.M., Foster J.R., Chang S.C., Ehresman D.J., Noker P.E., Butenhoff J.L. Evaluation of hepatic and thyroid responses in male Sprague Dawley rats for up to eighty-four days following seven days of dietary exposure to potassium perfluorooctanesulfonate. Toxicology 2012, 293:30-40.
18. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
19. Feng X., Wang Z., Fillmore R., Xi Y. MiR-200, a new star miRNA in human cancer. Cancer Lett. 2014, 344:166-173.
20. Finch M.L., Marquardt J.U., Yeoh G.C., Callus B.A. Regulation of microRNAs and their role in liver development, regeneration and disease. Int. J. Biochem. Cell Biol. 2014, 54:288-303.
21. Fornari F., Milazzo M., Galassi M., Callegari E., Veronese A., Miyaaki H., Sabbioni S., Mantovani V., Marasco E., Chieco P., et al. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma. Mol. Cancer Res. 2014, 12:203-216.
22. Goodnight J., Harvey W. SAS Technical Report R-103, Lease-Squares Means in the Fixed-Effects General Linear Models 1997.
23. Goto Y., Kojima S., Nishikawa R., Enokida H., Chiyomaru T., Kinoshita T., Nakagawa M., Naya Y., Ichikawa T., Seki N. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Oncotarget 2014, 5:7748-7759.
24. He X.X., Guo A.Y., Xu C.R., Chang Y., Xiang G.Y., Gong J., Dan Z.L., Tian D.A., Liao J.Z., Lin J.S. Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties. Oncol. Rep. 2014, 32:1200-1210.
25. Hoffman K., Webster T.F., Weisskopf M.G., Weinberg J., Vieira V.M. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ. Health Perspect. 2010, 118:1762-1767.
26. Hood A., Klaassen C.D. Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation. Toxicol. Sci. 2000, 55:78-84.
27. Hung C.S., Liu H.H., Liu J.J., Yeh C.T., Chang T.C., Wu C.H., Ho Y.S., Wei P.L., Chang Y.J. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. Ann. Surg. Oncol. 2013, 20(Suppl. 3):S360-S368.
28. Hunten S., Siemens H., Kaller M., Hermeking H. The p53/microRNA network in cancer: experimental and bioinformatics approaches. Adv. Exp. Med. Biol. 2013, 774:77-101.
29. Hwang M.S., Yu N., Stinson S.Y., Yue P., Newman R.J., Allan B.B., Dornan D. miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer. PLOS ONE 2013, 8:e66502.
30. Jackson A.F., Williams A., Recio L., Waters M.D., Lambert I.B., Yauk C.L. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. Toxicol. Appl. Pharmacol. 2014, 274:63-77.
31. Jin T., Ding Q., Huang H., Xu D., Jiang Y., Zhou B., Li Z., Jiang X., He J., Liu W., et al. PAQR10 and PAQR11 mediate Ras signaling in the Golgi apparatus. Cell Res. 2012, 22:661-676.
32. Koufaris C., Wright J., Currie R.A., Gooderham N.J. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. Toxicol. Sci. 2012, 128:532-543.
33. Koufaris C., Wright J., Osborne M., Currie R.A., Gooderham N.J. Time and dose-dependent effects of phenobarbital on the rat liver miRNAome. Toxicology 2013, 314:247-253.
34. Liu J., Ruan B., You N., Huang Q., Liu W., Dang Z., Xu W., Zhou T., Ji R., Cao Y., et al. Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the beta-catenin pathway in hepatic oval cells. PLOS ONE 2013, 8:e79409.
35. Liu W.H., Tao K.S., You N., Liu Z.C., Zhang H.T., Dou K.F. Differences in the properties and miRNA expression profiles between side populations from hepatic cancer cells and normal liver cells. PLoS ONE 2011, 6:e23311.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
37. Majid S., Dar A.A., Saini S., Deng G., Chang I., Greene K., Tanaka Y., Dahiya R., Yamamura S. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLOS ONE 2013, 8:e67686.
38. Malik A.I., Rowan-Carroll A., Williams A., Lemieux C.L., Long A.S., Arlt V.M., Phillips D.H., White P.A., Yauk C.L. Hepatic genotoxicity and toxicogenomic responses in MutaMouse males treated with dibenz[a,h]anthracene. Mutagenesis 2013, 28:543-554.
39. Malik A.I., Williams A., Lemieux C.L., White P.A., Yauk C.L. Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation. Environ. Mol. Mutagen. 2012, 53:10-21.
40. Martin M.T., Brennan R.J., Hu W., Ayanoglu E., Lau C., Ren H., Wood C.R., Corton J.C., Kavlock R.J., Dix D.J. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol. Sci. 2007, 97:595-613.
41. Moffat I.D., Boutros P.C., Celius T., Linden J., Pohjanvirta R., Okey A.B. microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol. Sci. 2007, 99:470-487.
42. Murakami Y., Toyoda H., Tanaka M., Kuroda M., Harada Y., Matsuda F., Tajima A., Kosaka N., Ochiya T., Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE 2011, 6:e16081.
43. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
44. Nakahara S., Tsutsumi K., Zuinen T., Ohta Y. FilGAP, a Rho-ROCK-regulated GAP for Rac, controls adherens junctions in MDCK cells. J. Cell. Sci. 2015, 128:2047-2056.
45. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
46. Pellegrino L., Stebbing J., Braga V.M., Frampton A.E., Jacob J., Buluwela L., Jiao L.R., Periyasamy M., Madsen C.D., Caley M.P., et al. miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts. Nucleic Acids Res. 2013, 41:5400-5412.
47. Pogribny I.P., Muskhelishvili L., Tryndyak V.P., Beland F.A. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol. 2009, 235:305-311.
48. Ramadoss P., Abraham B.J., Tsai L., Zhou Y., Costa-e-Sousa R.H., Ye F., Bilban M., Zhao K., Hollenberg A.N. Novel mechanism of positive versus negative regulation by thyroid hormone receptor beta1 (TRbeta1) identified by genome-wide profiling of binding sites in mouse liver. J. Biol. Chem. 2014, 289:1313-1328.
49. Ren H., Vallanat B., Nelson D.M., Yeung L.W., Guruge K.S., Lam P.K., Lehman-McKeeman L.D., Corton J.C. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species. Reprod. Toxicol. 2009, 27:266-277.
50. Rong M., Chen G., Dang Y. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer 2013, 13. 21-2407-13-21.
51. Rosen M.B., Lee J.S., Ren H., Vallanat B., Liu J., Waalkes M.P., Abbott B.D., Lau C., Corton J.C. Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR. Toxicol. Sci. 2008, 103:46-56.
52. Rosen M.B., Schmid J.E., Das K.P., Wood C.R., Zehr R.D., Lau C. Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid. Reprod. Toxicol. 2009, 27:278-288.
53. Rosen M.B., Schmid J.R., Corton J.C., Zehr R.D., Das K.P., Abbott B.D., Lau C. Gene expression profiling in wild-type and PPARalpha-null mice exposed to perfluorooctane sulfonate reveals PPARalpha-independent effects. PPAR Res. 2010, 2010. 10.1155/2010/794739.
54. Ross S.A., Davis C.D. The emerging role of microRNAs and nutrition in modulating health and disease. Annu. Rev. Nutr. 2014, 34:305-336.
55. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 2002, 68:249-264.
56. Searle S., Speed F., Milliken G. The population marginal means in linear model: an alternative to least squares means. Am. Stat. 1980, 34:216-221.
57. Shi Z., Zhang J., Qian X., Han L., Zhang K., Chen L., Liu J., Ren Y., Yang M., Zhang A., Pu P., Kang C. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. Cancer Res. 2013, 73:5519-5531.
58. Stinson S., Lackner M.R., Adai A.T., Yu N., Kim H.J., O'Brien C., Spoerke J., Jhunjhunwala S., Boyd Z., Januario T., et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci. Signal. 2011, 4:pt5.
59. Su A., He S., Tian B., Hu W., Zhang Z. MicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells. PLOS ONE 2013, 8:e71309.
60. Takaki Y., Saito Y., Takasugi A., Toshimitsu K., Yamada S., Muramatsu T., Kimura M., Sugiyama K., Suzuki H., Arai E., et al. Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis. Cancer. Sci. 2014, 105:1254-1260.
61. Trebicka J., Anadol E., Elfimova N., Strack I., Roggendorf M., Viazov S., Wedemeyer I., Drebber U., Rockstroh J., Sauerbruch T., Dienes H.P., Odenthal M. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J. Hepatol. 2013, 58:234-239.
62. Tsai W.C., Hsu S.D., Hsu C.S., Lai T.C., Chen S.J., Shen R., Huang Y., Chen H.C., Lee C.H., Tsai T.F., et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 2012, 122:2884-2897.
63. Wang F., Liu W., Jin Y., Wang F., Ma J. Prenatal and neonatal exposure to perfluorooctane sulfonic acid results in aberrant changes in miRNA expression profile and levels in developing rat livers. Environ. Toxicol. 2015, 30:712-723.
64. Wang F., Liu W., Ma J., Yu M., Jin Y., Dai J. Prenatal and neonatal exposure to perfluorooctane sulfonic acid results in changes in miRNA expression profiles and synapse associated proteins in developing rat brains. Environ. Sci. Technol. 2012, 46:6822-6829.
65. Wang S.C., Lin X.L., Li J., Zhang T.T., Wang H.Y., Shi J.W., Yang S., Zhao W.T., Xie R.Y., Wei F., et al. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA. PLOS ONE 2014, 9:e101330.
66. Webster A.F., Williams A., Recio L., Yauk C.L. Gene expression analysis of livers from female B6C3F1 mice exposed to carcinogenic and non-carcinogenic doses of furan, with or without bromodeoxyuridine (BrdU) treatment. Genomics Data 2014, 2:117.
67. Yan S., Wang J., Zhang W., Dai J. Circulating microRNA profiles altered in mice after 28d exposure to perfluorooctanoic acid. Toxicol. Lett. 2014, 224:24-31.
68. Yang M.H., Chen C.L., Chau G.Y., Chiou S.H., Su C.W., Chou T.Y., Peng W.L., Wu J.C. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50:1464-1474.
69. Yang N., Ekanem N.R., Sakyi C.A., Ray S.D. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv. Drug Deliv. Rev. 2015, 81C:62-74.
70. Yauk C.L., Jackson K., Malowany M., Williams A. Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. Mutat. Res. 2011, 722:131-139.
71. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001, 81:1097-1142.
72. Zeisberg M., Yang C., Martino M., Duncan M.B., Rieder F., Tanjore H., Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 2007, 282:23337-23347.
73. Zhang L., Li Y.Y., Zeng H.C., Wei J., Wan Y.J., Chen J., Xu S.Q. MicroRNA expression changes during zebrafish development induced by perfluorooctane sulfonate. J. Appl. Toxicol. 2011, 31:210-222.
74. Zhao J., Tang N., Wu K., Dai W., Ye C., Shi J., Zhang J., Ning B., Zeng X., Lin Y. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLOS ONE 2014, 9:e108005.